XML 150 R83.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
ATM Facility
Common Stock
Additional Paid-in Capital
ATM Facility
Additional Paid-in Capital
Accumulated Other Comprehensive Loss Investments
Accumulated Deficit
ATM Facility
Total
Beginning balance (in shares) at Dec. 31, 2018   77,456,180            
Beginning balance at Dec. 31, 2018   $ 77   $ 230,154   $ (186,024)   $ 44,207
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) Attributable to Parent           (107,500)   (107,500)
Share-based compensation       1,237       $ 1,237
Exercise of stock options (in shares)   89,812           90,000
Exercises of stock options       98       $ 98
Exercise of common stock warrants (in shares)   6,772,928            
Exercises of common stock warrants   $ 7   5,474       5,481
Issuance of common stock and common stock warrants (in shares) 2,062,206 20,410,000            
Issuance of common stock and common stock warrants $ 2 $ 21 $ 1,934 27,812     $ 1,936 27,833
Ending balance (in shares) at Dec. 31, 2019   106,801,409            
Ending balance at Dec. 31, 2019   $ 107   266,717   (293,524)   (26,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) Attributable to Parent           (22,397)   (22,397)
Share-based compensation       1,757       $ 1,757
Exercise of stock options (in shares)   12,000           12,000
Exercises of stock options       13       $ 13
Exercise of common stock warrants (in shares)   238,110            
Exercises of common stock warrants       131       131
Issuance of common stock and common stock warrants (in shares) 33,369,942              
Issuance of common stock and common stock warrants $ 33   37,925       37,958  
Ending balance (in shares) at Dec. 31, 2020   140,449,647            
Ending balance at Dec. 31, 2020   $ 140   306,554   (315,921)   (9,227)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) Attributable to Parent           (55,512)   (55,512)
Share-based compensation       958       958
Exercise of stock options (in shares)   30,610            
Exercises of stock options       39       39
Exercise of common stock warrants (in shares)   852,840            
Exercises of common stock warrants   $ 1   468       469
Issuance of common stock and common stock warrants (in shares) 30,645,702              
Issuance of common stock and common stock warrants $ 31   72,512       72,543  
Ending balance (in shares) at Mar. 31, 2021   171,978,799            
Ending balance at Mar. 31, 2021   $ 172   380,531   (371,433)   9,270
Beginning balance (in shares) at Dec. 31, 2020   140,449,647            
Beginning balance at Dec. 31, 2020   $ 140   306,554   (315,921)   (9,227)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) Attributable to Parent               (9,280)
Unrealized gain of investments               0
Ending balance (in shares) at Sep. 30, 2021   199,463,645            
Ending balance at Sep. 30, 2021   $ 199   486,010   (325,201)   161,008
Beginning balance (in shares) at Dec. 31, 2020   140,449,647            
Beginning balance at Dec. 31, 2020   $ 140   306,554   (315,921)   (9,227)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) Attributable to Parent           (336)   (336)
Share-based compensation       5,143       $ 5,143
Exercise of stock options (in shares)   33,610           34,000
Exercises of stock options       42       $ 42
Exercise of common stock warrants (in shares)   2,048,059           2,048,000
Exercises of common stock warrants   $ 2   1,124       $ 1,126
Issuance of common stock and common stock warrants (in shares) 56,932,329              
Issuance of common stock and common stock warrants $ 57   174,905       174,962  
Ending balance (in shares) at Dec. 31, 2021   199,463,645            
Ending balance at Dec. 31, 2021   $ 199   487,768 $ 0 (316,257)   171,710
Beginning balance (in shares) at Mar. 31, 2021   171,978,799            
Beginning balance at Mar. 31, 2021   $ 172   380,531   (371,433)   9,270
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) Attributable to Parent           (25,442)   (25,442)
Share-based compensation       1,260       1,260
Issuance of common stock and common stock warrants (in shares) 16,482,152              
Issuance of common stock and common stock warrants $ 16   64,245       64,261  
Ending balance (in shares) at Jun. 30, 2021   188,460,951            
Ending balance at Jun. 30, 2021   $ 188   446,036   (396,875)   49,349
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) Attributable to Parent           71,674   71,674
Share-based compensation       1,168       1,168
Exercise of stock options (in shares)   3,000            
Exercises of stock options       3       3
Exercise of common stock warrants (in shares)   1,195,219            
Exercises of common stock warrants   $ 1   656       657
Issuance of common stock and common stock warrants (in shares) 9,804,475              
Issuance of common stock and common stock warrants $ 10   $ 38,147       $ 38,157  
Unrealized gain of investments               0
Ending balance (in shares) at Sep. 30, 2021   199,463,645            
Ending balance at Sep. 30, 2021   $ 199   486,010   (325,201)   161,008
Beginning balance (in shares) at Dec. 31, 2021   199,463,645            
Beginning balance at Dec. 31, 2021   $ 199   487,768 0 (316,257)   171,710
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) Attributable to Parent           (807)   (807)
Share-based compensation       1,894       1,894
Ending balance (in shares) at Mar. 31, 2022   199,463,645            
Ending balance at Mar. 31, 2022   $ 199   489,662 0 (317,064)   172,797
Beginning balance (in shares) at Dec. 31, 2021   199,463,645            
Beginning balance at Dec. 31, 2021   $ 199   487,768 0 (316,257)   171,710
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) Attributable to Parent               $ (12,310)
Exercise of stock options (in shares)               0
Exercise of common stock warrants (in shares)               0
Unrealized gain of investments               $ (235)
Ending balance (in shares) at Sep. 30, 2022   202,757,012            
Ending balance at Sep. 30, 2022   $ 202   493,629 (235) (328,567)   165,029
Beginning balance (in shares) at Mar. 31, 2022   199,463,645            
Beginning balance at Mar. 31, 2022   $ 199   489,662 0 (317,064)   172,797
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) Attributable to Parent           (31,960)   (31,960)
Share-based compensation       1,802       1,802
Unrealized gain of investments         (281)     (281)
Ending balance (in shares) at Jun. 30, 2022   199,463,645            
Ending balance at Jun. 30, 2022   $ 199   491,464 (281) (349,024)   142,358
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) Attributable to Parent           20,457   20,457
Share-based compensation (in shares)   3,293,367            
Share-based compensation   $ 3   2,165       2,168
Unrealized gain of investments         46     46
Ending balance (in shares) at Sep. 30, 2022   202,757,012            
Ending balance at Sep. 30, 2022   $ 202   $ 493,629 $ (235) $ (328,567)   $ 165,029